newsfilter
← Latest News
GlobeNewswire·

Collegium Announces $150 Million Share Repurchase Program

STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical